Comparison of Eplivanserin and Lormetazepam in the Treatment of Insomnia Characterized by Sleep Maintenance Difficulties

NCT00679900 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

283

Enrollment

INDUSTRY

Sponsor class

Conditions

Sleep Initiation and Maintenance Disorders

Interventions

DRUG: eplivanserin (SR46349)
DRUG: lormetazepam

Sponsor

Sanofi